Table 2.

Associations between GAS5 rs145204276 and 579 patients with prostate cancer.

Genetic model	Genotype	Controls (N=579) n (%)	Patients (N=579) n (%)	OR (95% CI)	p value
Codominant model	Ins/Ins	237 (40.9%)	263 (45.4%)	1.000
	Ins/Del	270 (46.7%)	252 (43.5%)	0.841 (0.658-1.075)	p=0.167
	Del/Del	72 (12.4%)	64 (11.1%)	0.801 (0.548-1.171)	p=0.252
Dominant model	Ins/Ins	237 (40.9%)	263 (45.4%)	1.000
	Ins/Del + Del/Del	342 (59.1%)	316 (54.6%)	0.833 (0.660-1.051)	p=0.123
Recessive model	Ins/Ins + Ins/Del	507 (87.6%)	515 (88.9%)	1.000
	Del/Del	72 (12.4%)	64 (11.1%)	0.875 (0.612-1.252)	p=0.465
Additive model	Ins allele	744 (64.2%)	778 (67.2%)	1.000
	Del allele	414 (35.8%)	380 (32.8%)	0.878 (0.739-1.042)	p=0.137

The odds ratios (ORs) and with their 95% confidence intervals (CIs) were estimated by logistic regression models.